文献速递睡眠呼吸障碍

疑似阻塞性睡眠呼吸暂停管理:家庭呼吸多导描记非劣于实验室多导睡眠图

Conventional Polysomnography Is Not Necessary for the Management of Most Patients with Suspected Obstructive Sleep Apnea. Noninferiority, Randomized Controlled Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01

该多中心非劣效随机对照试验在西班牙12家三级医院纳入430例疑似睡眠呼吸暂停患者,比较家庭呼吸多导描记与实验室多导睡眠图管理方案。主要结局Epworth嗜睡量表显示呼吸多导描记非劣于多导睡眠图,生活质量、血压和随访多导睡眠图相似,且每例患者费用降低416.7€。

要点

  • 家庭呼吸多导描记管理对疑似睡眠呼吸暂停患者6个月效果非劣于实验室多导睡眠图。
  • 两种方案在生活质量、血压及随访多导睡眠图结果上相似。
  • 家庭呼吸多导描记更具成本效益,每例患者费用降低416.7€。

核心结论

  • 家庭呼吸多导描记管理对疑似睡眠呼吸暂停患者与多导睡眠图管理效果相似,且费用显著更低。

研究设计与样本

  • 多中心、非劣效、随机对照试验,两开放平行组,并做成本效益分析,在西班牙12家三级医院进行。
  • 共随机430例疑似睡眠呼吸暂停患者,分别接受呼吸多导描记或多导睡眠图管理方案。

主要发现

  • 基于Epworth嗜睡量表,呼吸多导描记方案非劣于多导睡眠图方案,非劣效界值为-2分。
  • 两种方案在生活质量、血压和随访多导睡眠图结果上相似。
  • 呼吸多导描记最具成本效益,每例患者费用降低416.7€。

关键数值与推荐

  • 非劣效 criterion 为Epworth嗜睡量表-2分。
  • 呼吸多导描记每例患者费用降低416.7€。

临床怎么用

  • 对多数疑似睡眠呼吸暂停患者,可采用家庭呼吸多导描记管理替代实验室多导睡眠图,以降低成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Home respiratory polygraphy may be a simpler alternative to in-laboratory polysomnography for the management of more symptomatic patients with obstructive sleep apnea, but its effectiveness has not been evaluated across a broad clinical spectrum. OBJECTIVES: To compare the long-term effectiveness (6 mo) of home respiratory polygraphy and polysomnography management protocols in patients with intermediate-to-high sleep apnea suspicion (most patients requiring a sleep study). METHODS: A multicentric, noninferiority, randomized controlled trial with two open parallel arms and a cost-effectiveness analysis was performed in 12 tertiary hospitals in Spain. Sequentially screened patients with sleep apnea suspicion were randomized to respiratory polygraphy or polysomnography protocols. Moreover, both arms received standardized therapeutic decision-making, continuous positive airway pressure (CPAP) treatment or a healthy habit assessment, auto-CPAP titration (for CPAP indication), health-related quality-of-life questionnaires, 24-hour blood pressure monitoring, and polysomnography at the end of follow-up. The main outcome was the Epworth Sleepiness Scale measurement. The noninferiority criterion was -2 points on the Epworth scale. MEASUREMENTS AND MAIN RESULTS: In total, 430 patients were randomized. The respiratory polygraphy protocol was noninferior to the polysomnography protocol based on the Epworth scale. Quality of life, blood pressure, and polysomnography were similar between protocols. Respiratory polygraphy was the most cost-effective protocol, with a lower per-patient cost of 416.7€. CONCLUSIONS: Home respiratory polygraphy management is similarly effective to polysomnography, with a substantially lower cost. Therefore, polysomnography is not necessary for most patients with suspected sleep apnea. This finding could change established clinical practice, with a clear economic benefit. Clinical trial registered with www.clinicaltrials.gov (NCT 01752556).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Corral J, Sánchez-Quiroga MÁ, Carmona-Bernal C, et al. Conventional Polysomnography Is Not Necessary for the Management of Most Patients with Suspected Obstructive Sleep Apnea. Noninferiority, Randomized Controlled Trial. Am J Respir Crit Care Med. 2017. PMID: 28636405. doi:10.1164/rccm.201612-2497OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。